Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Blood Cells, Molecules & Diseases|February 23, 2010
The aryl hydrocarbon receptor: regulation of hematopoiesis and involvement in the progression of blood diseasesFanny L Casado, Kameshwar P Singh, Thomas A Gasiewicz
The Journal of Biological Chemistry|February 24, 2004
The aryl hydrocarbon receptor (AhR) tyrosine 9, a residue that is essential for AhR DNA binding activity, is not a phosphoresidue but augments AhR phosphorylationGary D Minsavage, Sang-ki Park, Thomas A Gasiewicz
Archives of Biochemistry and Biophysics|March 21, 2003
Mutational analysis of the mouse aryl hydrocarbon receptor tyrosine residues necessary for recognition of dioxin response elementsGary D Minsavage, Daria P Vorojeikina, Thomas A Gasiewicz
Toxicological Sciences : an Official Journal of the Society of Toxicology|November 26, 2009
TCDD and a putative endogenous AhR ligand, ITE, elicit the same immediate changes in gene expression in mouse lung fibroblastsEllen C Henry, Stephen L Welle, Thomas A Gasiewicz
Toxicology and Applied Pharmacology|May 16, 2002
2,3,7,8-tetrachlorodibenzo-p-dioxin does not directly alter the phenotype of maturing B cells in a murine coculture systemAmber Wyman, Amy L Lavin, Gregory E Wilding, et al.
Neurotoxicology|June 9, 2004
Presence and functional activity of the aryl hydrocarbon receptor in isolated murine cerebral vascular endothelial cells and astrocytesCarissa R Filbrandt, Zhenhua Wu, Berislav Zlokovic, et al.
Biochemical Pharmacology|November 6, 2008
The aryl hydrocarbon receptor has a normal function in the regulation of hematopoietic and other stem/progenitor cell populationsKameshwar P Singh, Fanny L Casado, Lisa A Opanashuk, et al.
Stem Cells and Development|September 30, 2010
Aryl hydrocarbon receptor-null allele mice have hematopoietic stem/progenitor cells with abnormal characteristics and functionsKameshwar P Singh, Russell W Garrett, Fanny L Casado, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 22, 2015
The heat shock protein 90 inhibitor, (-)-epigallocatechin gallate, has anticancer activity in a novel human prostate cancer progression modelMichael A Moses, Ellen C Henry, William A Ricke, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 23, 2003
The Jun N-terminal kinase inhibitor SP600125 is a ligand and antagonist of the aryl hydrocarbon receptorAby Joiakim, Patricia A Mathieu, Christine Palermo, et al.
Pageof 4